Capricor Therapeutics (CAPR) Short-term Investments: 2012-2025
Historic Short-term Investments for Capricor Therapeutics (CAPR) over the last 9 years, with Sep 2025 value amounting to $79.1 million.
- Capricor Therapeutics' Short-term Investments rose 374.77% to $79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.1 million, marking a year-over-year increase of 374.77%. This contributed to the annual value of $140.2 million for FY2024, which is 465.60% up from last year.
- As of Q3 2025, Capricor Therapeutics' Short-term Investments stood at $79.1 million, which was down 20.59% from $99.6 million recorded in Q2 2025.
- Capricor Therapeutics' 5-year Short-term Investments high stood at $140.2 million for Q4 2024, and its period low was $16.7 million during Q3 2024.
- In the last 3 years, Capricor Therapeutics' Short-term Investments had a median value of $33.7 million in 2024 and averaged $55.5 million.
- Per our database at Business Quant, Capricor Therapeutics' Short-term Investments slumped by 48.86% in 2023 and then surged by 465.60% in 2024.
- Quarterly analysis of 4 years shows Capricor Therapeutics' Short-term Investments stood at $31.8 million in 2022, then declined by 22.08% to $24.8 million in 2023, then soared by 465.60% to $140.2 million in 2024, then spiked by 374.77% to $79.1 million in 2025.
- Its Short-term Investments was $79.1 million in Q3 2025, compared to $99.6 million in Q2 2025 and $116.0 million in Q1 2025.